Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical characteristics and outcomes of patients with BRCA1 or RAD51C methylated versus mutated ovarian carcinoma

Published:2018-02 Issue:2 Volume:148 Page:281-285
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bernards Sarah S.,Pennington Kathryn P.,Harrell Maria I.,Agnew Kathy J.,Garcia Rochelle L.,Norquist Barbara M.,Swisher Elizabeth M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. Integrated genomic analyses of ovarian carcinoma;Bell;Nature,2011

2. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas;Pennington;Clin. Cancer Res.,2014

3. Inherited mutations in women with ovarian carcinoma;Norquist;JAMA Oncol.,2016

4. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer;Zhang;Gynecol. Oncol.,2011

5. Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients;Vencken;Ann. Oncol.,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of BRCA1 promoter methylation for patients with epithelial ovarian cancer;Journal of Gynecology Obstetrics and Human Reproduction;2024-09

2. High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers;NAR Cancer;2024-07-09

3. Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer;Cancer Medicine;2024-04

4. Evaluation of Homologous Recombination Deficiency in Ovarian Cancer;Current Treatment Options in Oncology;2024-02

5. Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition;Acta Biochimica et Biophysica Sinica;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3